The MarketWatch News Department was not involved in the creation of this content.
Apr 12, 2023 (The Expresswire) --The latest market research report on the Global "Transdermal Patch Market" is segmented by Regions, Country, Company and other Segments. The global Transdermal Patch market is dominated by key Players, such as [Hisamitsu Pharmaceutical, Johnson and Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal, IBSA Group, GSK, Luye Pharma Group, Pfizer, Chattem, Dr Reddyâs Laboratories, Bayer, Mundipharma, Endo International, Beijing Tide Pharmaceutical] these players have adopted various strategies to increase their market penetration and strengthen their position in the industry. Stake holders and other participants in the global Transdermal Patch market will be able to gain the upper hand by using the report as a powerful resource for their business needs.
Number of Tables and Figures : 154
What is the Transdermal Patch market growth?
Transdermal Patch Market Size is projected to Reach Multimillion USD by 2030, In comparison to 2023, at unexpected CAGR during the forecast Period 2023-2030.
Browse Detailed TOC, Tables and Figures with Charts which is spread across 110 Pages that provides exclusive data, information, vital statistics, trends, and competitive landscape details in this niche sector.
Client Focus 1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Transdermal Patch market?
Final Report will add the analysis of the impact of Russia-Ukraine War and COVID-19 on this Transdermal Patch Industry.
TO KNOW HOW COVID-19 PANDEMIC AND RUSSIA UKRAINE WAR WILL IMPACT THIS MARKET - REQUEST SAMPLE
This research report is the result of an extensive primary and secondary research effort into the Transdermal Patch market. It provides a thorough overview of the market's current and future objectives, along with a competitive analysis of the industry, broken down by application, type and regional trends. It also provides a dashboard overview of the past and present performance of leading companies. A variety of methodologies and analyses are used in the research to ensure accurate and comprehensive information about the Transdermal Patch Market.
Which are the driving factors of the Transdermal Patch market?
Growing demand for [Rx Channel, OTC Channel] around the world has had a direct impact on the growth of the Transdermal Patch
The Transdermal Patch segments and sub-section of the market are illuminated below:
Based on Product Types the Market is categorized into [Methyl Salicylate-based Patch, Rivastigmine Transdermal Patch, Fentanyl Transdermal Patch, Lidocaine Patch, Diclofenac Patch, Nicotine Transdermal Patch, Others] that held the largest Transdermal Patch market share In 2022.
Get a Sample PDF of report -https://www.360researchreports.com/enquiry/request-sample/21057387
Transdermal Patch Market - Competitive and Segmentation Analysis:
2.How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Short Description About Transdermal Patch Market:
The Global Transdermal Patch market is anticipated to rise at a considerable rate during the forecast period, between 2022 and 2030. In 2021, the market is growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Market Analysis and Insights: Global Transdermal Patch Market
Due to the COVID-19 pandemic, the global Transdermal Patch market size is estimated to be worth USD 6793 million in 2021 and is forecast to a readjusted size of USD 8726.9 million by 2028 with a CAGR of 3.6Percent during the forecast period 2022-2028.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18Percent, followed by Lidocaine Patches, with 15Percent.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76Percent of the total.
Hisamitsu Pharmaceutical, Johnson and Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42Percent of the global market in 2019.
Global Transdermal Patch Scope and Market Size
The global Transdermal Patch market is segmented by region (country), company, by Type and by Application. Players, stakeholders, and other participants in the global Transdermal Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Get a Sample Copy of the Transdermal Patch Report 2023
3.What are your main data sources?Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users. Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapters:
● North America (United States, Canada and Mexico)
● Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
● Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
● South America (Brazil, Argentina, Columbia etc.)
● Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
This Transdermal Patch Market Research/Analysis Report Contains Answers to your following Questions
● What are the global trends in the Transdermal Patch market? Would the market witness an increase or decline in the demand in the coming years?
● What is the estimated demand for different types of products in Transdermal Patch? What are the upcoming industry applications and trends for Transdermal Patch market?
● What Are Projections of Global Transdermal Patch Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about Import and Export?
● Where will the strategic developments take the industry in the mid to long-term?
● What are the factors contributing to the final price of Transdermal Patch? What are the raw materials used for Transdermal Patch manufacturing?
● How big is the opportunity for the Transdermal Patch market? How will the increasing adoption of Transdermal Patch for mining impact the growth rate of the overall market?
● How much is the global Transdermal Patch market worth? What was the value of the market In 2020?
● Who are the major players operating in the Transdermal Patch market? Which companies are the front runners?
● Which are the recent industry trends that can be implemented to generate additional revenue streams?
● What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Transdermal Patch Industry?
Customization of the Report
Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Inquire more and share questions if any before the purchase on this report at -https://www.360researchreports.com/enquiry/pre-order-enquiry/21057387
Detailed TOC of Global Transdermal Patch Market Insights and Forecast to 2030
Major Points from Table of Contents
Global Transdermal Patch Market Research Report 2023-2030, by Manufacturers, Regions, Types and Applications
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East and Africa)
1.4 Years Considered for the Study (2015-2030)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Transdermal Patch Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Transdermal Patch Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Transdermal Patch Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Transdermal Patch Market-Segmentation by Type
6 Global Transdermal Patch Market-Segmentation by Application
7 Global Transdermal Patch Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence Company Profiles
9 Global Transdermal Patch Market-Segmentation by Geography
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Latin America
9.5 Middle East and Africa
10 Future Forecast of the Global Transdermal Patch Market from 2023-2030
10.1 Future Forecast of the Global Transdermal Patch Market from 2023-2030 Segment by Region
10.2 Global Transdermal Patch Production and Growth Rate Forecast by Type (2023-2030)
10.3 Global Transdermal Patch Consumption and Growth Rate Forecast by Application (2023-2030)
11 Appendix
11.1 Methodology
12.2 Research Data Source
Continued….
Purchase this report (Price 3350 USD for a single-user license) -https://www.360researchreports.com/purchase/21057387
About Us:
360 Research Reports is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Research Reports, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.
For More Related Reports:-
What is the scenario for PVA Fiber, Industry?
Which end-use industry is poised to account for bulk of Digital Pressure Controllers Market demand?
Mechanical Watch Market Growth and Forecast till 2031
The Food Market is anticipated to boost sales at a Impressive CAGR
Integrated Workplace Management (IWMS) Systems Market In-depth analysis which provides critical revenue and estimates for the period 2023 To 2029
Mutual Fund Assets Market 2023 Segmented by Types, Application, Key Players and Regional Analysis to 2028
Portable Concrete Mixer Market Size and Forecast till 2031
Lubricating Paste Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2028
Flux Cored Welding Wire Market Growth and Forecast till 2031
Coiling Coating Market 2023 : Incredible Possibilities, Growth Analysis and Forecast To 2028
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Transdermal Patch Market Size and Forecast till 2030
COMTEX_429035829/2598/2023-04-12T00:41:12
Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.
The MarketWatch News Department was not involved in the creation of this content.
FAQs
How big is the market for transdermal patches? ›
| Report Metric | Details |
|---|---|
| Forecast Period 2021 to 2027 CAGR: | 3.6% |
| 2028 Value Projection: | USD 8726.9 Million |
| No. of Pages: | 119 |
| Tables & Figures | 164 |
Due to the COVID-19 pandemic, the global Transdermal Patch market size is estimated to be worth USD 6793 million in 2021 and is forecast to a readjusted size of USD 8726.9 million by 2028 with a CAGR of 3.6Percent during the forecast period 2022-2028.
What is the manufacturing process of transdermal drug delivery system? ›The manufacturing process of a TDS involves several unit operations such as mixing of drug and adhesive, coating or laminating the drug in adhesive mixture followed by drying, die cutting to desired shape and size and packaging (Van Buskirk et al., 1997; Wolff, 2000) .
How are transdermal patches made? ›They consist of: a support layer, an adhesive matrix containing the active ingredient and a release layer that is discarded when the product is applied to the skin. The manufacturing process consists of the following stages: Mixing. Coating, Drying and Laminating.
What is the failure rate of transdermal patch? ›Birth control patch effectiveness
That means about 7 out of 100 patch users get pregnant each year.
Transdermal patches deliver medication more directly to the bloodstream by bypassing processing in the liver. Transdermal patches deliver medication over a longer period of time than traditional systems, which can be easier on patients who experience extreme side effects.
What is the price of transdermal patch machine? ›Transdermal Patch Making Lab Machine - VJ Instruments at Rs 450000/unit, Karanja | ID: 19176672348.
What is the most common transdermal patch? ›One of the first transdermal patches developed was the nitroglycerin patch in 1985. The patch developed by Gale and Berggren (1985) utilizes an ethylene vinyl acetate rate-controlling membrane. Perhaps the most common and well known transdermal patch is the nicotine patch used to aid the cessation of smoking.
What is an example of marketed transdermal patches? ›Transdermal drug administration refers to substances that are absorbed through the skin. Some of the most common examples of these are nicotine patches or patches that contain painkillers, such as prescription opioids.
What are the disadvantages of transdermal patches? ›- It does not provide protection against sexually transmitted infections (STIs), including HIV.
- Must be prescribed by a health care provider.
- The estrogen levels are higher with the patch than with other hormonal methods.
What are the two main types of transdermal drug delivery system? ›
Most commercially available transdermal drug delivery systems are of three different types, namely reservoir systems, matrix systems with rate-controlling membrane, and matrix systems without rate-controlling membrane.
What are advantages and disadvantages of transdermal drug delivery system? ›The delivery of drugs via transdermal routes is an attractive approach due to ease of administration, bypassing of the first-pass metabolism, and the large skin surface area. However, a major drawback is an inability to surmount the skin's stratum corneum (SC) layer.
Who invented transdermal patch? ›The first of these systems was a combination of a reservoir containing the active and a rate-controlling membrane pioneered in the early 1970s by the entrepreneur Alejandro Zaffaroni through his company Alza. His first commercialized TTS was a scopolamine TTS.
What are the 4 layers of transdermal patch? ›Transdermal patch design
These designs characteristically are composed of four layers: an impermeable backing membrane; a drug reservoir; a semi-permeable membrane that may serve as a rate-limiting barrier; and an adhesive layer.
Common disadvantages of TDDS: 1,3-5
Many drugs especially drugs with hydrophilic structures permeate the skin too slowly may not achieve therapeutic level. 2. The drug, the adhesive or other excipients in the patch formulation can cause erythema, itching, and local edema. 3.
Perrigo has discontinued scopolamine transdermal system due to business reasons. — The discontinuation is not due to product quality, safety, or efficacy concerns. — Scopolamine transdermal system has been listed on the FDA Drug Shortage site. Upon further research, Perrigo confirmed discontinuation of the product.
What are three limitations of transdermal drug usage? ›Some of the disadvantages associated with transdermal drug delivery include potential skin sensitization or irritation, discomfort from adhesives, imperfect skin adhesion, cost and selectivity for specific physicochemical drug properties (Erdő et al., 2016).
What is the major problem of transdermal drug delivery route? ›The greatest challenge with transdermal drug delivery is the barrier nature of skin, which is provided by its outer layer, that is, the stratum corneum (SC). This barrier limits the number of drugs, which are capable of being administered via this route.
How long are most transdermal patches effective? ›Fentanyl is a strong opioid. The transdermal patch is a long-acting formulation with a delayed onset of effect initially and a prolonged duration of action; plasma concentrations are halved about 17 hours after removal. It is unsuitable for acute pain. Each patch lasts 72 hours.
What is the conclusion of transdermal patch? ›Transdermal Patch offers many advantages over the conventional dosage forms or controlled release oral systems. Transdermal patch provides constant blood levels, avoids first pass metabolism, increased patient compliance, and avoids dose dumping [1,2].
Are transdermal patches better than pills? ›
Although comparable to oral-dosage forms in efficacy, transdermal patches have numerous advantages over oral forms. First, transdermal administration avoids the first-pass effect of metabolism associated with the oral route. Therefore, transdermal administration allows for improved bioavailability.
How many transdermal patches are there? ›There are five main types of transdermal patches.
Is transdermal patch a narcotic? ›Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics.
Do you massage a transdermal patch? ›Drugs given by injection or patch
If your client wears a medication patch, avoid massaging the area around the patch, and do not remove or move the patch at any time. Similar precautions should be taken with any hormone cream or topical medication.
Apply the patch to a dry, flat skin area on your upper arm, chest, or back. Choose a place where the skin is not very oily and is free of scars, cuts, burns, or irritation.
What are the two advantages of transdermal medication patches? ›Transdermal delivery offers several benefits over oral delivery, including smooth, continuous drug delivery, increased bioavailability, and reduced drug-drug interactions. Patches can be easily applied by the caregiver, and they provide a visual cue that the medication has been administered.
What are two advantages of transdermal patch? ›They can substitute for oral administration of medication when that route is unsuitable. To avoid the first pass effect . They are non-invasive and have patient compliance. They are less greasy and can be easily removed from the skin.
What is the trade name for transdermal patch? ›BRAND NAME(S): Nitro-Dur, Transderm-Nitro. USES: This medication is used to prevent chest pain (angina) in people with a certain heart condition (coronary artery disease). Nitroglycerin belongs to a class of drugs known as nitrates.
What disease is transdermal patch used for? ›Transdermal drugs are medications used in managing and treating various conditions, including hypertension, motion sickness, pain, migraines, etc.
What is the purpose of a transdermal patch? ›What Are Transdermal Patches? Transdermal patches adhere to the skin as a way to deliver drugs. They provide a specific, predetermined dose of medication that is absorbed through the skin and into the bloodstream.
Who is the manufacturer of transdermal patches? ›
Sparsha Pharma International Pvt. Ltd. is India's First Transdermal Drug Delivery Company (2008) Engaged in the Research & Development, Manufacturing and Marketing of Transdermal products. Contribute to the wellbeing of patients through innovative, safe, effective and affordable transdermal products across the globe.
What was the first FDA approved transdermal patches? ›The first transdermal system for systemic delivery—a three-day patch that delivers scopolamine to treat motion sickness—was approved for use in the United States in 1979.
What are the 2 most common drugs given transdermal? ›Drugs commonly administered transdermally include: Nicotine. Fentanyl (opioid).